EyeGate begins patient enrollment in anterior uveitis study Pharmaceutical Business Review The Phase III randomized double-masked positive-controlled non-inferiority trial is expected to enroll around 200 subjects to investigate the efficiency of EGP-437 in comparison to topically applied prednisolone acetate eye drops. ... EyeGate Pharma begins phase 3 study on potential treatment for anterior uveitis |
